Addex Therapeutics Ltd (SWX:ADXN)

Addex Therapeutics Statistics

Total Valuation

SWX:ADXN has a market cap or net worth of CHF 6.80 million. The enterprise value is 5.20 million.

Market Cap	6.80M
Enterprise Value	5.20M

Important Dates

The next confirmed earnings date is Monday, June 15, 2026.

Earnings Date	Jun 15, 2026
Ex-Dividend Date	n/a

Share Statistics

SWX:ADXN has 147.83 million shares outstanding. The number of shares has increased by 14.31% in one year.

Current Share Class	147.83M
Shares Outstanding	147.83M
Shares Change (YoY)	+14.31%
Shares Change (QoQ)	+21.58%
Owned by Insiders (%)	15.05%
Owned by Institutions (%)	1.46%
Float	123.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	39.34
PB Ratio	1.43
P/TBV Ratio	1.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.77
EV / Sales	30.06
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.40, with a Debt / Equity ratio of 0.01.

Current Ratio	1.40
Quick Ratio	1.38
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,162.58

Financial Efficiency

Return on equity (ROE) is -94.75% and return on invested capital (ROIC) is -24.23%.

Return on Equity (ROE)	-94.75%
Return on Assets (ROA)	-20.64%
Return on Invested Capital (ROIC)	-24.23%
Return on Capital Employed (ROCE)	-54.49%
Weighted Average Cost of Capital (WACC)	15.10%
Revenue Per Employee	57,620
Profits Per Employee	-2.24M
Employee Count	2
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.39% in the last 52 weeks. The beta is 1.98, so SWX:ADXN's price volatility has been higher than the market average.

Beta (5Y)	1.98
52-Week Price Change	-23.39%
50-Day Moving Average	0.04
200-Day Moving Average	0.05
Relative Strength Index (RSI)	47.36
Average Volume (20 Days)	181,676

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SWX:ADXN had revenue of CHF 172,860 and -6.73 million in losses. Loss per share was -0.06.

Revenue	172,860
Gross Profit	-497,821
Operating Income	-2.81M
Pretax Income	-6.84M
Net Income	-6.73M
EBITDA	-2.81M
EBIT	-2.81M
Loss Per Share	-0.06

Balance Sheet

The company has 1.64 million in cash and 34,688 in debt, with a net cash position of 1.60 million or 0.01 per share.

Cash & Cash Equivalents	1.64M
Total Debt	34,688
Net Cash	1.60M
Net Cash Per Share	0.01
Equity (Book Value)	4.77M
Book Value Per Share	0.03
Working Capital	481,160

Cash Flow

Operating Cash Flow	-2.17M
Capital Expenditures	n/a
Depreciation & Amortization	424
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	-287.99%
Operating Margin	-1,628.25%
Pretax Margin	-3,958.46%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SWX:ADXN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.31%
Shareholder Yield	-14.31%
Earnings Yield	-98.94%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SWX:ADXN has an Altman Z-Score of -78.3 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-78.3
Piotroski F-Score	1